Novo Nordisk obesity pipeline sup treatment gap Maturation of innovation Innovation curve Body weight set-point and counter regulation Weight loss prediction for patient groups Normalised weight Oral product 20-30% weight loss Saxenda® Today Targeted treatment solutions 10-15% weight loss Lau Sax Pha Semaglut Pha AM Pha PYY Tri-a GG-co LA-G Sema+
Download PDF file